HIF activation identifies early lesions in VHL kidneys
Open accessThe DOI matches its Crossref record, with a small difference in title or year; 51 of the 51 references it cites were found in a registry or an index.
Abstract
Mutations in the von Hippel-Lindau (VHL) gene are associated with hereditary and sporadic clear cell renal carcinoma. VHL acts in a ubiquitin ligase complex regulating hypoxia-inducible factor-1 (HIF-1), but the link between this function and cancer development is unclear. Here we show that in the kidneys of patients with VHL disease, HIF activation is an early event occurring in morphologically normal single cells within the renal tubules. In comparison, dysplastic lesions, cystic lesions, and tumors showed evidence of additional mechanisms that amplify HIF activation. Detection of cells with constitutive HIF activation identified a large number of previously unrecognized foci of VHL inactivation. In proximal tubules these were almost entirely unicellular, whereas multicellular foci were almost exclusively seen in the distal nephron.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“By contrast, the appearance of HIF-2α protein in these early lesions is associated with increased dysplasia and cellular atypia [21].”
From Revisiting the HIF switch in the tumor and its immune microenvironment. (2022) · cites this paper as [21]
In the citing paper
“However, HIF-1α is believed to play an important role during ccRCC initiation, and is elevated in the earliest pre-neoplastic lesions in VHL patients [21].”
From Revisiting the HIF switch in the tumor and its immune microenvironment. (2022) · cites this paper as [21]
Citations
Cites
Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
Hanahan, D., & Folkman, J. (1996) · Cell · doi:10.1016/s0092-8674(00)80108-7 · Cited by 6,885
Jaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535
Self-citationThe tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
Self-citationLessons from hereditary colorectal cancer
Kinzler, K. W., & Vogelstein, B. (1996) · Cell · doi:10.1016/s0092-8674(00)81333-1 · Cited by 4,919
HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735
Epstein, A. C. R., Gleadle, J. M., McNeill, L. A., Hewitson, K. S., O'Rourke, J., Mole, D. R., Mukherji, M., Metzen, E., Wilson, M. I., Dhanda, A., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00507-4 · Cited by 3,333
Self-citationIdentification of the von Hippel-Lindau Disease Tumor Suppressor Gene
Latif, F., Tory, K., Gnarra, J., Yao, M., Duh, F.-M., Orcutt, M. L., Stackhouse, T., Kuzmin, I., Modi, W., Geil, L., et al. (1993) · Science · doi:10.1126/science.8493574 · Cited by 2,973
Self-citationA conserved family of prolyl-4-hydroxylases that modify HIF
Bruick, R. K., & McKnight, S. L. (2001) · Science · doi:10.1126/science.1066373 · Cited by 2,549
Cellular and developmental control of O 2 homeostasis by hypoxia-inducible factor 1α
Iyer, N. V., Kotch, L. E., Agani, F., Leung, S. W., Laughner, E., Wenger, R. H., Gassmann, M., Gearhart, J. D., Lawler, A. M., Yu, A. Y., et al. (1998) · Genes & Development · doi:10.1101/gad.12.2.149 · Cited by 2,476
Motzer, R. J., Bander, N. H., & Nanus, D. M. (1996) · New England Journal of Medicine · doi:10.1056/nejm199609193351207 · Cited by 2,219
Research works printed but not linked: 2
- de Paulsen, 2001, Role of transforming growth factor-α in von Hippel-Lindau (VHL)(−/−) clear cell renal carcinoma cell proliferation, Proc. Natl. Acad. Sci. USA, 98, 1387
- Haase, 2001, Consequences of conditional inactivation of the VHL tumor suppressor in the murine renal cortex, JASN, 12, A2870
Cited by
Targeting HIF-1 for cancer therapy
Semenza, G. L. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1187 · Cited by 6,717
Lonser, R. R., Glenn, G. M., Walther, M., Chew, E. Y., Libutti, S. K., Linehan, W. M., & Oldfield, E. H. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13643-4 · Cited by 1,600
Cohen, H. T., & McGovern, F. J. (2005) · New England Journal of Medicine · doi:10.1056/nejmra043172 · Cited by 1,554
The impact of O2 availability on human cancer
Bertout, J. A., Patel, S. A., & Simon, M. C. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2540 · Cited by 1,365
HIF-1 mediates metabolic responses to intratumoral hypoxia and oncogenic mutations
Semenza, G. L. (2013) · Journal of Clinical Investigation · doi:10.1172/jci67230 · Cited by 1,335
Metadata
- Authors
- Mandriota, S. J., Turner, K. J., Davies, D. R., Murray, P. G., Morgan, N. V., Sowter, H. M., Wykoff, C. C., Maher, E. R., Harris, A. L., Ratcliffe, P. J., & Maxwell, P. H.
- Affiliations
- Centre for Human Genetics (GB)
- Cancer Research UK (GB)
- John Radcliffe Hospital (GB)
- University of Birmingham (GB)
- Corresponding author
- Maxwell, Patrick H
- ORCID
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2002-06
- Volume
- 1
- Issue
- 5
- Pages
- 459-468
- ISSN
- 1535-6108 (ISSN-L)
- OpenAlex
- W2024064023
- Semantic Scholar
- 50363d44112fe73aa8cde47b92b36af749ae3508
- Cited by
- 483
- References
- 51
- Citations by year
- 2026: 10 · 2025: 8 · 2024: 21 · 2023: 11 · 2022: 19 · 2021: 18 · 2020: 17 · 2019: 14 · 2018: 26 · 2017: 18 · 2016: 14 · 2015: 19 · 2014: 18 · 2013: 34 · 2012: 23
- FWCI
- 8.07
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 4064 d)
- Locations
- Cancer Cell (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- Funders
- Wellcome Trust
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Health Sciences › Medicine › Oncology › Renal cell carcinoma treatment
- Health Sciences › Medicine › Oncology › Ear and Head Tumors
- Keywords
- von Hippel-Lindau gene, von Hippel-Lindau disease, HIF-1, HIF activation, clear cell renal cell carcinoma, renal tubules, proximal tubule, distal nephron, renal dysplasia, renal cysts, ubiquitin ligase
- MeSH terms
- Carbonic Anhydrase IX, Adult, Antigens, Neoplasm, Carbonic Anhydrases, Carcinoma, Renal Cell, DNA-Binding Proteins, von Hippel-Lindau Disease, Humans, Immunoenzyme Techniques, Kidney Neoplasms, Middle Aged, Monosaccharide Transport Proteins, Neoplasm Proteins, Nephrectomy, Nephrons, Nuclear Proteins, Transcription Factors, RNA Probes, Antigens, CD, Genes, Tumor Suppressor, Apoptosis, In Situ Hybridization, Adenocarcinoma, Clear Cell, In Situ Nick-End Labeling, Glucose Transporter Type 1, Hypoxia-Inducible Factor 1, Hypoxia-Inducible Factor 1, alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: HIF activation identifies early lesions in VHL kidneys. https://app.cochat.ai/papers/10.1016/s1535-6108(02)00071-5
- The paper
- Mandriota, S. J., Turner, K. J., Davies, D. R., Murray, P. G., Morgan, N. V., Sowter, H. M., Wykoff, C. C., Maher, E. R., Harris, A. L., Ratcliffe, P. J., & Maxwell, P. H. (2002). HIF activation identifies early lesions in VHL kidneys. Cancer Cell. https://doi.org/10.1016/s1535-6108(02)00071-5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.